Oral azithromycin for treatment of posterior blepharitis.

Abstract

PURPOSE:

To evaluate the effects of oral azithromycin in patients with posterior blepharitis.

METHODS:

Twenty-six eyes of 13 patients with posterior blepharitis diagnosed by a qualified ophthalmologist were enrolled in this study. Patients were instructed to use oral azithromycin 500 mg per day for 3 days in 3 cycles with 7-day intervals. Subjective clinical outcomes were graded and scored 1 day before and 30 days after the end of the treatment (53 days after initiating the treatment) based on severity scores of: (1) eyelid debris; (2) eyelid telangiectasia; (3) swelling of the eyelid margin; (4) redness of the eyelid margin; and (5) ocular mucus secretion. For the assessment of global efficacy, patients were asked by the investigator to rate the subjective symptoms (eyelid itching, ocular itching, eyelid hyperemia, ocular hyperemia, ocular mucus secretion, photophobia, foreign body sensation, and dry eye sensation) on a scale of 0 (no symptoms) to 5 (severe symptoms). Break-up time, Schirmer I test, corneal fluorescein staining score, and rose bengal staining score were also performed in all patients.

RESULTS:

All clinical outcomes scoring showed statistically significant improvement after oral azithromycin, except for eyelid swelling. Average subjective symptom grading improved statistically after treatment with oral azithromycin, except for eyelid hyperemia, photophobia, and foreign body sensation. Average tear film break-up time values showed statistically significant improvement after the treatment with oral azithromycin. No statistically significant improvement was observed on average values of Schirmer I test, corneal fluorescein staining score, and rose bengal staining score.

CONCLUSIONS:

The combination of multiple clinical parameters shown in this study supports the clinical efficacy of pulsed oral azithromycin therapy for the management of posterior blepharitis.

• Authors: Thais Zamudio Igami, Ricardo Holzchuh, Tammy Hentona Osaki, Ruth Miyuki Santo, Newton Kara-Jose, Richard Y Hida
• Journal: Cornea (Cornea) Vol. 30 Issue 10 Pg. 1145-9 (Oct 2011) ISSN: 1536-4798 [Electronic] United States
• PMID: 21849891 (Publication Type: Journal Article)

Chemical References

• Anti-Bacterial Agents
• Azithromycin

Topics

• Administration, Oral
• Anti-Bacterial Agents (administration & dosage)
• Azithromycin (administration & dosage)
• Blepharitis (drug therapy, microbiology)
• Eye Infections, Bacterial (drug therapy, microbiology)
• Female
• Humans
• Hyperemia (drug therapy, physiopathology)
• Male
• Meibomian Glands (drug effects, microbiology)
• Middle Aged
• Prospective Studies
• Pruritus (drug therapy, physiopathology)
• Pulse Therapy, Drug
• Tears (chemistry)
• Treatment Outcome